The future of valvular heart disease assessment and therapy
- 27 March 2024
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 403 (10436) , 1590-1602
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation
This publication has 112 references indexed in Scilit:
- Clinical value of CT‐derived simulations of transcatheter‐aortic‐valve‐implantation in challenging anatomies the PRECISE‐TAVI trialCatheterization and Cardiovascular Interventions, 2023
- Accountability in artificial intelligence: what it is and how it worksAI & SOCIETY, 2023
- Lipoprotein(a) and its Significance in Cardiovascular DiseaseJAMA Cardiology, 2022
- Clinically Undetectable Heart Sounds in Hospitalized Patients Undergoing EchocardiographyJAMA Internal Medicine, 2021
- Utility of a Deep-Learning Algorithm to Guide Novices to Acquire Echocardiograms for Limited Diagnostic UseJAMA Cardiology, 2021
- Point‐of‐care ultrasound: Closing guideline gaps in screening for valvular heart diseaseClinical Cardiology, 2020
- An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER TrialJAMA Cardiology, 2020
- Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot studyOsteoporosis International, 2020
- Association of LPA Variants With Aortic StenosisJAMA Cardiology, 2018
- Inhibition of antigen-presenting cell function by alendronate in vitroJournal of Bone and Mineral Research, 1995